All stock lists
Oncotelic Therapeutics, Inc. (OTC:OTLC)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.02+0.00 (+8.11%)
Market cap
$9.15M
Insider Score
Health Score
Listed since
Aug 26, 1993
Website
Insider Score
––Not scored
OTLC Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
OTLC analyst forecast
No analyst ratings in the last 12 months
No independent sell-side analyst publishes on OTLC that our data provider carries. That is normal for smaller listings, and it is not a judgement on the company. Here is what we track instead:
- Insider activity and the Insider Score — what the people who run the company are doing with their own money.
- Promoter Scores — any disclosed paid stock promotion on this ticker.
Best analysts covering OTLC
No firm covering OTLC has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
OTLC earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-17 | 0.00 | -0.00 | $0 | $0 |
| 2026-04-15 | -0.02 | 0.59 | $0 | $0 |
| 2026-05-14 | -0.02 | -0.00 | $500K | $0 |
| 2026-08-13 | -0.02 | 0.00 | $500K | $250K |
| 2026-11-18Upcoming | -0.02 | — | $500K | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.